Public trial registry of the CCC-Munich

Trial PF 04449913

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
PF 04449913
World
Full title
:

A Randomized (1:1), Double blind, Multi center, Placebo Controlled Study EVALUATING Intensive Chemotherapy With or Without Glasdegib (PF 0444913) or Azacitidine With or Without Glasdegib in Patients With Previously Untreated Acute Myeloid Leukemia

World
Description
:

Phase III, Multi-zentrisch, Doppelblind, Randomisiert, Placebo-Kontrolliert

World
EudraCT number
:
World
Responsible organization
:
KUM Med3- Medizinische Klinik und Poliklinik Lmu
Indications
Classification Code Description
Trial design
World
Blinding type
:
Double blinded
World
Phase
:
III
Status
World
Status
:
Recruitment active
Votes
World
Institutional review board - vote
:
Unknown
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Participants The lead of this trial has not explicitely given their approval for publishing the contact information of the principal investigators or specific contact persons.